Fidelity Investments’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $629M | Buy |
10,818,491
+1,898,241
| +21% | +$87.5M | 0.03% | 426 |
|
|
2025
Q4 | $400M | Buy |
8,920,250
+1,343
| +0% | +$56.4K | 0.02% | 593 |
|
|
2025
Q3 | $358M | Buy |
8,918,907
+34,544
| +0.4% | +$1.22M | 0.02% | 624 |
|
|
2025
Q2 | $278M | Buy |
8,884,363
+596,864
| +7% | +$19.5M | 0.02% | 692 |
|
|
2025
Q1 | $278M | Buy |
8,287,499
+762,209
| +10% | +$28.9M | 0.02% | 673 |
|
|
2024
Q4 | $295M | Buy |
7,525,290
+607,606
| +9% | +$25.1M | 0.02% | 664 |
|
|
2024
Q3 | $272M | Buy |
6,917,684
+149,511
| +2% | +$6.03M | 0.02% | 702 |
|
|
2024
Q2 | $264M | Buy |
6,768,173
+166,343
| +3% | +$6.65M | 0.02% | 687 |
|
|
2024
Q1 | $284M | Buy |
6,601,830
+945,908
| +17% | +$43.5M | 0.02% | 646 |
|
|
2023
Q4 | $261M | Buy |
5,655,922
+1,403,056
| +33% | +$49.6M | 0.02% | 647 |
|
|
2023
Q3 | $145M | Sell |
4,252,866
-935,841
| -18% | -$35M | 0.01% | 823 |
|
|
2023
Q2 | $200M | Buy |
5,188,707
+460,858
| +10% | +$18.3M | 0.02% | 718 |
|
|
2023
Q1 | $169M | Buy |
4,727,849
+37,020
| +0.8% | +$1.37M | 0.02% | 773 |
|
|
2022
Q4 | $185M | Buy |
4,690,829
+21,070
| +0.5% | +$767K | 0.02% | 714 |
|
|
2022
Q3 | $169M | Buy |
4,669,759
+97,391
| +2% | +$3.5M | 0.02% | 744 |
|
|
2022
Q2 | $139M | Buy |
4,572,368
+738,892
| +19% | +$22.3M | 0.01% | 831 |
|
|
2022
Q1 | $117M | Sell |
3,833,476
-76,541
| -2% | -$2.29M | 0.01% | 1008 |
|
|
2021
Q4 | $122M | Buy |
3,910,017
+853,261
| +28% | +$25.5M | 0.01% | 1017 |
|
|
2021
Q3 | $46.7M | Sell |
3,056,756
-15,688
| -0.5% | -$273K | ﹤0.01% | 1439 |
|
|
2021
Q2 | $57.2M | Sell |
3,072,444
-14,800
| -0.5% | -$273K | ﹤0.01% | 1369 |
|
|
2021
Q1 | $55.3M | Buy |
3,087,244
+461,692
| +18% | +$7.83M | ﹤0.01% | 1350 |
|
|
2020
Q4 | $40.4M | Buy |
2,625,552
+932
| +0% | +$10.9K | ﹤0.01% | 1404 |
|
|
2020
Q3 | $29.1M | Buy |
2,624,620
+425,566
| +19% | +$5.01M | ﹤0.01% | 1414 |
|
|
2020
Q2 | $27.6M | Buy |
2,199,054
+611,518
| +39% | +$7.78M | ﹤0.01% | 1424 |
|
|
2020
Q1 | $18M | Buy |
+1,587,536
| New | +$22.6M | ﹤0.01% | 1448 |
|
|
2016
Q1 | – | Sell |
-910,920
| Closed | -$7.32M | – | 2748 |
|
|
2015
Q4 | $7.32M | Hold |
910,920
| – | – | ﹤0.01% | 2089 |
|
|
2015
Q3 | $7.52M | Sell |
910,920
-230,142
| -20% | -$2.29M | ﹤0.01% | 2048 |
|
|
2015
Q2 | $13.2M | Sell |
1,141,062
-115,177
| -9% | -$1.59M | ﹤0.01% | 1910 |
|
|
2015
Q1 | $21.2M | Hold |
1,256,239
| – | – | ﹤0.01% | 1711 |
|
|
2014
Q4 | $24.8M | Buy |
+1,256,239
| New | +$18.4M | ﹤0.01% | 1644 |
|
Other funds holding XENE
ACA
DCM
PCH
